141 related articles for article (PubMed ID: 26287271)
1. Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2).
Kaur J; Tietz O; Bhardwaj A; Marshall A; Way J; Wuest M; Wuest F
ChemMedChem; 2015 Oct; 10(10):1635-40. PubMed ID: 26287271
[TBL] [Abstract][Full Text] [Related]
2. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
Bhardwaj A; Kaur J; Wuest F; Knaus EE
ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
[TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo.
Kniess T; Laube M; Bergmann R; Sehn F; Graf F; Steinbach J; Wuest F; Pietzsch J
Bioorg Med Chem; 2012 Jun; 20(11):3410-21. PubMed ID: 22560838
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold.
Tietz O; Sharma SK; Kaur J; Way J; Marshall A; Wuest M; Wuest F
Org Biomol Chem; 2013 Dec; 11(46):8052-64. PubMed ID: 24145766
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET).
Wüst FR; Höhne A; Metz P
Org Biomol Chem; 2005 Feb; 3(3):503-7. PubMed ID: 15678189
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
7. PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.
Perrone MG; Malerba P; Uddin J; Vitale P; Panella A; Crews BC; Daniel CK; Ghebreselasie K; Nickels M; Tantawy MN; Manning HC; Marnett LJ; Scilimati A
Eur J Med Chem; 2014 Jun; 80():562-568. PubMed ID: 24832612
[TBL] [Abstract][Full Text] [Related]
8. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
Tietz O; Kaur J; Bhardwaj A; Wuest FR
Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
12. Efficient sequential synthesis of PET Probes of the COX-2 inhibitor [11C]celecoxib and its major metabolite [11C]SC-62807 and in vivo PET evaluation.
Takashima-Hirano M; Takashima T; Katayama Y; Wada Y; Sugiyama Y; Watanabe Y; Doi H; Suzuki M
Bioorg Med Chem; 2011 May; 19(9):2997-3004. PubMed ID: 21482120
[TBL] [Abstract][Full Text] [Related]
13. Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides.
Tsai WJ; Shiao YJ; Lin SJ; Chiou WF; Lin LC; Yang TH; Teng CM; Wu TS; Yang LM
Bioorg Med Chem Lett; 2006 Sep; 16(17):4440-3. PubMed ID: 16814546
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
Abdelall EKA; Lamie PF; Ali WAM
Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM
Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer.
Gao M; Wang M; Miller KD; Zheng QH
Eur J Med Chem; 2011 Sep; 46(9):4760-7. PubMed ID: 21640445
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
